CAPONE, EMILY
 Distribuzione geografica
Continente #
NA - Nord America 1.396
EU - Europa 903
AS - Asia 837
SA - Sud America 134
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.290
Nazione #
US - Stati Uniti d'America 1.370
SG - Singapore 431
IT - Italia 303
CN - Cina 205
IE - Irlanda 157
BR - Brasile 117
SE - Svezia 96
DE - Germania 75
VN - Vietnam 58
FR - Francia 46
IN - India 42
FI - Finlandia 41
GB - Regno Unito 40
TR - Turchia 40
UA - Ucraina 35
RU - Federazione Russa 27
CA - Canada 16
BE - Belgio 13
AT - Austria 12
NL - Olanda 12
PL - Polonia 12
ZA - Sudafrica 11
HK - Hong Kong 10
ES - Italia 8
JP - Giappone 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
AR - Argentina 7
LT - Lituania 6
CH - Svizzera 5
GR - Grecia 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
MX - Messico 4
BD - Bangladesh 3
EG - Egitto 3
UZ - Uzbekistan 3
VE - Venezuela 3
BB - Barbados 2
EC - Ecuador 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
TW - Taiwan 2
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NI - Nicaragua 1
NP - Nepal 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.290
Città #
Singapore 294
Chandler 207
Dublin 155
Ashburn 98
The Dalles 82
Jacksonville 71
Beijing 68
Dallas 68
Princeton 53
Santa Clara 53
Pescara 52
Los Angeles 47
Ann Arbor 43
Chieti 43
New York 39
Munich 35
Boardman 29
Altamura 27
Dong Ket 22
Buffalo 20
Dearborn 20
Izmir 18
Nanjing 18
Wilmington 18
Denver 16
Hefei 15
Tongling 15
Lappeenranta 14
Turku 14
Brussels 13
Ho Chi Minh City 12
Stockholm 12
Brooklyn 11
Nuremberg 11
Redondo Beach 11
Hong Kong 10
Milan 10
São Paulo 10
Warsaw 10
Johannesburg 9
Montreal 9
Phoenix 9
Pune 9
Houston 8
Southend 8
Atlanta 7
Cambridge 7
Chennai 7
Falls Church 7
Hanoi 7
Hebei 7
Helsinki 7
London 7
Poplar 7
Seoul 7
Tokyo 7
Frankfurt am Main 6
L’Aquila 6
Rio de Janeiro 6
Dubai 5
Finale Ligure 5
Macerata 5
Nanchang 5
Norwalk 5
Salvador 5
Seattle 5
Vienna 5
Washington 5
Castignano 4
Chicago 4
Cleveland 4
Collecorvino 4
Mumbai 4
Orem 4
Putignano 4
Redwood City 4
San Francisco 4
Shijiazhuang 4
Woodbridge 4
Zhengzhou 4
Boston 3
Brno 3
Da Nang 3
Istanbul 3
L'aquila 3
Mcallen 3
Moscow 3
Ninh Bình 3
Perugia 3
Presidente Prudente 3
Providence 3
Querétaro 3
Rome 3
Silvi 3
Tappahannock 3
Tashkent 3
Zurich 3
Andover 2
Baghdad 2
Belo Horizonte 2
Totale 2.061
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 187
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 148
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 147
ABCC3 is a novel target for the treatment of pancreatic cancer 133
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 132
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 125
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 123
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 122
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 121
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 121
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 118
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 106
Normal breathing releases SARS-CoV-2 into the air 104
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 98
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 97
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 95
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 92
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 92
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 91
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 90
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 89
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 85
Antibody-drug conjugates: The new frontier of chemotherapy 84
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 80
HER-3: Hub for escape mechanisms 79
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 77
Endosialin-binding antibody 75
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 73
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 63
MYC regulates metabolism through vesicular transfer of glycolytic kinases 62
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 61
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 58
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 56
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 42
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 41
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 35
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 33
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 20
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 14
Totale 3.469
Categoria #
all - tutte 15.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 30 8 4 9 25 8 32
2021/2022175 6 3 4 25 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/20251.022 34 180 162 53 21 39 42 48 128 69 152 94
2025/2026823 154 70 138 218 228 15 0 0 0 0 0 0
Totale 3.469